scholarly journals Systemic vasculitis and patient-reported outcomes: how the assessment of patient preferences and perspectives could improve outcomes

2019 ◽  
Vol Volume 10 ◽  
pp. 37-42 ◽  
Author(s):  
Joanna C Robson ◽  
David Jayne ◽  
Peter A Merkel ◽  
Jill Dawson
Eye ◽  
2019 ◽  
Vol 34 (1) ◽  
pp. 205-210 ◽  
Author(s):  
Tianjing Li ◽  
Jimmy T. Le ◽  
Ronald D. Hays ◽  
Qi N. Cui ◽  
Malvina Eydelman ◽  
...  

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Helena Crawshaw ◽  
Matthew Wells ◽  
Keziah Austin ◽  
Shalini Janagan ◽  
Joanna C. Robson

2021 ◽  
Vol 23 (2) ◽  
Author(s):  
Joanna Robson ◽  
Sarah Mackie ◽  
Catherine Hill

Abstract Purpose of Review The goal of this paper is to review current and future uses of patient-reported outcomes in large vessel vasculitis. The large vessel vasculitides comprise Giant Cell Arteritis and Takayasu arteritis; both are types of systemic vasculitis which affect the larger blood vessels. Patient-reported outcomes (PROs) capture the impact of these diseases on health-related quality of life. Recent Findings Generic PROs such as the SF-36 are currently used to compare HRQOL of people with GCA and TAK within clinical trials and observational studies and to make comparisons with the general population and HRQoL in other diseases. The development of a disease-specific PRO for GCA is currently underway. Beyond clinical trials, there is much interest in the use of PROs within routine clinical care, particularly E-PROs for remote use. Summary Further work will be needed to complete the development of disease-specific PROs for people with large vessel vasculitis and to establish feasibility, acceptability, and utility of E-PROs.


2010 ◽  
Vol 3 (4) ◽  
pp. 217-227 ◽  
Author(s):  
Ateesha F. Mohamed ◽  
A. Brett Hauber ◽  
F. Reed Johnson ◽  
Cheryl D. Coon

Diagnostics ◽  
2021 ◽  
Vol 11 (9) ◽  
pp. 1730
Author(s):  
Ulrik Deding ◽  
Pablo Cortegoso Valdivia ◽  
Anastasios Koulaouzidis ◽  
Gunnar Baatrup ◽  
Ervin Toth ◽  
...  

Colon capsule endoscopy as an alternative to colonoscopy for the diagnosis of colonic disease may serve as a less invasive and more tolerable investigation for patients. Our aim was to examine patient-reported outcomes for colon capsule endoscopy compared to conventional optical colonoscopy including preference of investigation modality, tolerability and adverse events. A systematic literature search was conducted in Web of Science, PubMed and Embase. Search results were thoroughly screened for in- and exclusion criteria. Included studies underwent assessment of transparency and completeness, after which, data for meta-analysis were extracted. Pooled estimates of patient preference were calculated and heterogeneity was examined including univariate meta-regressions. Patient-reported tolerability and adverse events were reviewed. Out of fourteen included studies, twelve had investigated patient-reported outcomes in patients who had undergone both investigations, whereas in two the patients were randomized between investigations. Pooled patient preferences were estimated to be 52% (CI 95%: 41–63%) for colon capsule endoscopy and 45% (CI 95%: 33–57%) for conventional colonoscopy: not indicating a significant difference. Procedural adverse events were rarely reported by patients for either investigation. The tolerability was high for both colon capsule endoscopy and conventional colonoscopy. Patient preferences for conventional colonoscopy and colon capsule endoscopy were not significantly different. Procedural adverse events were rare and the tolerability for colon capsule endoscopy was consistently reported higher or equal to that of conventional colonoscopy.


Sign in / Sign up

Export Citation Format

Share Document